Annual Working Capital
-$6.84 M
-$5.02 M-274.78%
December 1, 2023
Summary
- As of February 12, 2025, ZVSA annual working capital is -$6.84 million, with the most recent change of -$5.02 million (-274.78%) on December 1, 2023.
- During the last 3 years, ZVSA annual working capital has risen by +$375.40 thousand (+5.20%).
- ZVSA annual working capital is now -274.78% below its all-time high of -$1.83 million, reached on December 31, 2022.
Performance
ZVSA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$11.15 M
-$1.80 M-19.23%
September 1, 2024
Summary
- As of February 12, 2025, ZVSA quarterly working capital is -$11.15 million, with the most recent change of -$1.80 million (-19.23%) on September 1, 2024.
- Over the past year, ZVSA quarterly working capital has dropped by -$4.47 million (-66.88%).
- ZVSA quarterly working capital is now -510.88% below its all-time high of -$1.83 million, reached on December 31, 2022.
Performance
ZVSA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ZVSA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -274.8% | -66.9% |
| 3 y3 years | +5.2% | +27.6% |
| 5 y5 years | +5.2% | +27.6% |
ZVSA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -274.8% | +46.6% | -510.9% | +27.6% |
| 5 y | 5-year | -274.8% | +46.6% | -510.9% | +27.6% |
| alltime | all time | -274.8% | +46.6% | -510.9% | +27.6% |
ZyVersa Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$11.15 M(+19.2%) |
| Jun 2024 | - | -$9.35 M(+40.0%) |
| Mar 2024 | - | -$6.68 M(-2.3%) |
| Dec 2023 | -$6.84 M | -$6.84 M(-29.5%) |
| Sep 2023 | - | -$9.70 M(+3.6%) |
| Jun 2023 | - | -$9.37 M(+63.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | -$5.74 M(+214.6%) |
| Dec 2022 | -$1.83 M(-85.8%) | -$1.83 M(-84.7%) |
| Sep 2022 | - | -$11.95 M(-22.5%) |
| Jun 2022 | - | -$15.41 M(+20.3%) |
| Dec 2021 | -$12.81 M(+77.6%) | - |
| Dec 2021 | - | -$12.81 M |
| Dec 2020 | -$7.22 M | - |
FAQ
- What is ZyVersa Therapeutics annual working capital?
- What is the all time high annual working capital for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics annual working capital year-on-year change?
- What is ZyVersa Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics quarterly working capital year-on-year change?
What is ZyVersa Therapeutics annual working capital?
The current annual working capital of ZVSA is -$6.84 M
What is the all time high annual working capital for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high annual working capital is -$1.83 M
What is ZyVersa Therapeutics annual working capital year-on-year change?
Over the past year, ZVSA annual working capital has changed by -$5.02 M (-274.78%)
What is ZyVersa Therapeutics quarterly working capital?
The current quarterly working capital of ZVSA is -$11.15 M
What is the all time high quarterly working capital for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high quarterly working capital is -$1.83 M
What is ZyVersa Therapeutics quarterly working capital year-on-year change?
Over the past year, ZVSA quarterly working capital has changed by -$4.47 M (-66.88%)